Drugs Archives - Page 15 of 65 - �鶹Ů�� Health News

The Kids Are Not OK

Episode 285

Feb. 16, 2023

A new survey from the Centers for Disease Control and Prevention finds that teenagers, particularly girls, are reporting all-time high rates of violence and profound mental distress. Meanwhile, both sides in the abortion debate are anxiously waiting for a district court decision in Texas that could effectively revoke the FDA’s 22-year-old approval of the abortion pill mifepristone. Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN’s chief Washington correspondent, Julie Rovner, to discuss these issues and more.

Listen Now

An illustration of two hands holding phones as large chat bubbles pop out from each phone. The chat bubble on the left shows a voting ballot box and exclamation points. The bubble on the right shows an insulin vial with dollar signs.

Armed With Hashtags, These Activists Made Insulin Prices a Presidential Talking Point

Twitter has been a hotbed for the burgeoning insulin access movement and activism surrounding other medical conditions. For people with diabetes, the platform has helped propel concern about insulin prices into policy. Can it continue to win with hashtags?

By Bram Sable-Smith

Feb. 15, 2023

Postcard From a Philadelphia Neighborhood

As Opioids Mixed With Animal Tranquilizers Arrive in Kensington, So Do Alarming Health Challenges

The veterinary tranquilizer xylazine, the choice du jour of local drug dealers to cut fentanyl, leads to necrotic ulcers and leaves street medics and physicians confused about how best to deal with this wave of the opioid crisis.

By Courtenay Harris Bond

Feb. 15, 2023

A man with black cloth covering his right eye over his glasses sits on the edge of a couch and looks off-camera to his left.

Your Money or Your Life: Patient on $50,000-a-Week Cancer Drug Fears Leaving Behind Huge Medical Debt

When Medicare stops paying for a pricey drug that prolongs life, an Ohio man considers giving up treatment to spare his family enormous debt.

By Fred Schulte

Feb. 14, 2023

Three photos are shown side-by-side. From left to right are a photo of a covid vaccine; a photo of a covid rapid test; a photo of Paxlovid.

COVID-19

Era of ‘Free’ Covid Vaccines, Test Kits, and Treatments Is Ending. Who Will Pay the Tab Now?

Insurers, employers, and taxpayers will all be affected as drug manufacturers move these products to the commercial market.

By Julie Appleby

Feb. 10, 2023

What the Health? From �鶹Ů�� Health News

A Health-Heavy State of the Union

Episode 284

Feb. 9, 2023

President Joe Biden’s 2023 State of the Union address leaned heavily on health care issues. Biden took a victory lap for recent accomplishments like capping prescription drug costs for seniors on Medicare. He also urged Congress to make permanent the boosted premium subsidies under the Affordable Care Act, and he sparred with Republicans on threats to cut Social Security and Medicare. Also this week, both sides in the abortion debate are bracing for a court decision out of Texas that could, at least temporarily, make the abortion pill mifepristone illegal nationwide. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Sarah Karlin-Smith of the Pink Sheet join KHN chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Kate Baicker of the University of Chicago about a possible middle ground in the effort to get universal health insurance coverage.

Listen Now

Centene Agrees to $215 Million Settlement With California for Alleged Medicaid Overbilling

The nation’s largest Medicaid insurer denies wrongdoing after the California attorney general’s office investigated it for inflating prescription drug costs.

By Samantha Young

Feb. 8, 2023

A photo shows Senator Bernie Sanders speaking into a microphone in front of the U.S. Capitol.

‘We Ain’t Gonna Get It’: Why Bernie Sanders Says His ‘Medicare for All’ Dream Must Wait

As he takes the reins of the Senate Health, Education, Labor & Pensions Committee, the independent from Vermont and implacable champion of “Medicare for All” maps out his strategy for negotiating with Republicans — and Big Pharma.

By Arthur Allen

Feb. 8, 2023

U.S. 100 bills strewn across a table with a gavel positioned downward to signify a court case

The Pill Club Reaches $18.3 Million Medicaid Fraud Settlement With California

The online women’s pharmacy agreed to pay $15 million to the state Department of Justice and $3.3 million to the Department of Insurance over claims it overbilled Medi-Cal.

By Don Thompson

Feb. 7, 2023

A photo shows Elizabeth Fisher Smith at home with her husband.

Decisions by CVS and Optum Panicked Thousands of Their Sickest Patients

Pharmacy closures by two of the biggest home infusion companies point to grave shortages and dangers for patients who require IV nutrition to survive.

By Arthur Allen

Feb. 7, 2023

An illustration shows 3D models of the RSV virus.

A Technicality Could Keep RSV Shots From Kids in Need

The Vaccines for Children program, which buys more than half the pediatric vaccines in the U.S., may not cover the RSV shot for babies because it’s not technically a vaccine.

By Arthur Allen

Feb. 6, 2023

Patients for Profit: How Private Equity Hijacked Health Care

Some Addiction Treatment Centers Turn Big Profits by Scaling Back Care

Private equity groups are cashing in on rising rates of alcohol and drug addiction in the U.S. But they aren’t necessarily investing in centers with the best treatment standards, and they often cut extra services.

By Renuka Rayasam and Blake Farmer, Nashville Public Radio

Jan. 31, 2023

What the Health? From �鶹Ů�� Health News

Part II: The State of the Abortion Debate 50 Years After ‘Roe’

Episode 282

Jan. 27, 2023

In Part II of this special two-part episode, Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Sarah Varney of KHN join KHN chief Washington correspondent Julie Rovner to discuss how the abortion debate has evolved since the Supreme Court overturned the nationwide right to abortion in 2022, and what might be the flashpoints for 2023. Also, for extra credit, the panelists recommend their most memorable reproductive health stories from the last year.

Listen Now

A photo shows a sign outside the FDA headquarters.

COVID-19

FDA Experts Are Still Puzzled Over Who Should Get Which Covid Shots and When

A single booster seems to prevent death and hospitalization in most people, but protection from the current vaccines wanes within months. FDA experts say they need to know more from the Centers for Disease Control and Prevention to decide the best long-term strategy.

By Arthur Allen

Jan. 27, 2023

Montana Pharmacists May Get More Power to Prescribe

Supporters of a proposed law say it would fill a health provider gap in rural areas, while doctors worry it will give pharmacists power outside the scope of their education.

By Keely Larson

Jan. 27, 2023

What the Health? From �鶹Ů�� Health News

Part I: The State of the Abortion Debate 50 Years After ‘Roe’

Episode 281

Jan. 26, 2023

In Part I of this special two-part episode, Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Sarah Varney of KHN join KHN chief Washington correspondent Julie Rovner to discuss how the abortion debate has evolved since the Supreme Court overturned the nationwide right to abortion in 2022, and what might be the flashpoints for 2023. Also in this episode, Rovner interviews Elizabeth Nash of the Guttmacher Institute, about changing reproductive policies in the states.

Listen Now

A box of 'Paxlovid' is in the center of the image. The box is white with blue text, with a thick a blue and red stripe on its left.

Navigating Aging

What Older Americans Need to Know About Taking Paxlovid

Covid-19 continues to hit seniors with disproportionate severity. Experts say Paxlovid is an effective therapy that is being underprescribed for people 65 and older.

By Judith Graham

Jan. 18, 2023

Postcard From San Francisco

The Biggest, Buzziest Conference for Health Care Investors Convenes Amid Fears the Bubble Will Burst

This year’s JPMorgan confab, the first since covid’s chilling effect on such gatherings, was full of energy and enthusiasm. But it was also marked by questions about the future of health care investment.

By Darius Tahir

Jan. 17, 2023

California Attorney General Sues Drugmakers Over Inflated Insulin Prices

California Attorney General Rob Bonta is taking three major drugmakers and three distributors to court, alleging the companies illegally raised prices at the expense of diabetes patients.

By Angela Hart and Samantha Young

Jan. 12, 2023

What the Health? From �鶹Ů�� Health News

GOP House Opens With Abortion Agenda

Episode 279

Jan. 12, 2023

Leaders of the new Republican-led U.S. House kicked off their legislative agenda with two bills supported by anti-abortion groups. While neither is likely to become law, the move demonstrates how abortion will continue to be an issue in Washington. Meanwhile, as open enrollment for the Affordable Care Act nears its end in most states, the number of Americans covered by the plans hits a new high. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these topics and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

Listen Now

�鶹Ů��

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

Drugs